A Randomized Controlled Clinical Study to Evaluate the Efficacy of Hinguvachadi tablet and tablet Mefanamic acid and Dicylomine in the management of painful menstruation.

A Randomized Controlled Clinical Study to Evaluate the Efficacy of Hinguvachadi gutika and tablet Mefanamic acid and Dicylomine in the management of Kashtaarthva. - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/11/076238

Enrollment

Registered

2024-11-04

Start date

Unknown

Completion date

Unknown

Last updated

2024-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N710- Acute inflammatory disease of uterus

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: All the women unmarried or married complaining of painfull menstruration at least 3 consecutive cycle

Exclusion criteria

Exclusion criteria: 1) Known Cases of secondary dysmenorrhea with pelvic pathology prolapse ,uterine fibroid, pelvic endometriosis, cervical stenosis ,Pelvic inflammatory Diseases. 2) Participant with intrauterine contraceptive device 3) Participant is on hormonal therapy.

Design outcomes

Primary

Measure	Time frame
Decrease in pain, duration and intensityTimepoint: 3 days	—

Secondary

Measure	Time frame
Decrease in pain, duration, clots and intensityTimepoint: 5 days	—

Countries

India

Contacts

Public ContactDr Mayur Pratapsing Ingale

Tilak Ayurved Mahavidyalaya

drrahulgarudkar@yahoo.com9422001871

Outcome results